Molecular Screening and Diagnosis of SARS-CoV-2: Recent Advances and Future Prospective
Avinash Kumar, Abhishek Kumar Verma and Mayadhar Barik.
Journal Title:Acta Scientific Microbiology
Background: COVID-19 is a new form of Coronavirus which is resembling the same as SARS-CoV-2. This virus leads to cause severe respiratory diseases among the people. Coronavirus is declared as the pandemic by the WHO on March 11, 2020. Transmission of the disease is mainly due to the person to person contact by any means
Materials and Methods: We detect the disease primary screening is necessary for a speedy recovery. PCR and other nucleic acid amplification are mainly used to diagnose the Covid-19. For the detection of the SARS, its gene is targeted in the amplification. The genes which are targeted are E, N, S, RdRp and ORf. Mutation in the SARS-CoV-2 genome is also detected by the various nucleic acid detection tests. We improve the detection of this pandemic, the only thing is to increase the involvement of Serological testing and molecular methods
Results: The majority of 85-95% factor becomes useful to overcome this disease is early detection rate of the disease SARS-CoV-2.Molecular and serological findings should need to work simultaneously for the improvement in the diagnosis and the treatment approximately 85% laboratory.
Conclusion: The only factor which becomes useful to overcome this disease is early detection of the disease.Molecular and serologicalstudyshould need to work simultaneously for the improvement in the diagnosis and the treatment. The need of the hour is to maintain and introduced laboratory networking and its application